Pharmaceutical Preparations
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| GILEAD SCIENCES, INC. | 16.71M | $500.0M | 25.35% | -- | 2026-06-30 |
| TANG CAPITAL MANAGEMENT LLC | 3.79M | $113.0M | 5.75% | -- | 2026-06-30 |
| Madison Avenue Partners, LP | 3.45M | $103.0M | 5.23% | +982.6K | 2026-06-30 |
| Prosight Management, LP | 2.04M | $61.0M | 3.10% | +493.3K | 2026-06-30 |
| EcoR1 Capital, LLC | 1.67M | $49.0M | 2.53% | -- | 2026-06-30 |
| AMERIPRISE FINANCIAL INC | 1.27M | $38.0M | 1.93% | -152.4K | 2026-06-30 |
| DME Capital Management, LP | 482.7K | $14.0M | 0.73% | -- | 2026-06-30 |
| RENAISSANCE TECHNOLOGIES LLC | 407.8K | $12.0M | 0.62% | +92.4K | 2026-06-30 |
| BlackRock, Inc. | 338.2K | $10.0M | 0.51% | +26.0K | 2026-06-30 |
| Point72 Asset Management, L.P. | 269.8K | $8.0M | 0.41% | -62.3K | 2026-06-30 |
